MAC Clinical Research
UK clinical research organization and site operator focused on complex CNS and psychedelic studies, with dedicated psychedelic testing suites and early-to-late phase delivery capabilities.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Trial Infrastructure Snapshot
Site Networks & SMOsService Model
Hybrid
Coverage
Global
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Verified
Apr 8, 2026
Lifecycle Coverage
Phase Coverage
Capabilities
Verification
Verified
Experience Notes
MAC publicly states active psychedelic protocols (including psilocybin, LSD, ketamine, and DMT) and dedicated infrastructure for psychedelic trial delivery.
Service Notes
Combines dedicated research sites, participant recruitment, and psychedelic trial execution support; also cited as a trial site for ibogaine clinical development programs.
Quick Facts
- Type
- Other
- HQ
- United Kingdom
- Website
- Visit